In compliance with the provisions of Regulation 24A of SEBI LODR Amendment Regulations, 2018, read with SEBI Circular dated February 08, 2019, GlaxoSmithKline Pharmaceuticals has informed that it enclosed Annual Secretarial Compliance Report of the Company for the financial year ended 31st March 2026.
The above information is a part of company’s filings submitted to BSE.